PHARMAC's response on clopidogrel.
Peter
P
Moodie
Sean
S
Dougherty
D000077144:Clopidogrel; D003362:Cost-Benefit Analysis; D004341:Drug Evaluation; D033161:Government Regulation; D006801:Humans; D009313:National Health Programs / Q000191:economics*; D009520:New Zealand; D010975:Platelet Aggregation Inhibitors / Q000191:economics*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000191:economics
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine